NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Johnson & Johnson announced a quarterly dividend on Thursday, January 2nd. Stockholders of record on Tuesday, February 25th will be given a dividend of $0.95 per share on Tuesday, March 10th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 2.55%. The ex-dividend date is Monday, February 24th. View Johnson & Johnson's Dividend History.

Johnson & Johnson declared that its board has authorized a share repurchase program on Monday, December 17th 2018, which authorizes the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 1.5% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.

Johnson & Johnson (NYSE:JNJ) announced its quarterly earnings results on Tuesday, October, 15th. The company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.00 by $0.12. The business had revenue of $20.73 billion for the quarter, compared to analysts' expectations of $20.14 billion. Johnson & Johnson had a return on equity of 39.81% and a net margin of 21.09%. The company's revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.05 earnings per share. View Johnson & Johnson's Earnings History.

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Johnson & Johnson.

Johnson & Johnson will be holding an earnings conference call on Wednesday, January 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

13 brokerages have issued 12 month target prices for Johnson & Johnson's stock. Their forecasts range from $145.00 to $173.00. On average, they anticipate Johnson & Johnson's stock price to reach $159.45 in the next twelve months. This suggests a possible upside of 6.9% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Media headlines about JNJ stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Johnson & Johnson earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Johnson & Johnson.

Johnson & Johnson saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 20,870,000 shares, an increase of 21.3% from the November 28th total of 17,210,000 shares. Based on an average daily trading volume, of 7,440,000 shares, the days-to-cover ratio is currently 2.8 days. Approximately 0.8% of the shares of the company are sold short. View Johnson & Johnson's Current Options Chain.

Some companies that are related to Johnson & Johnson include Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), Pfizer (PFE), Intel (INTC), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and Home Depot (HD).

Johnson & Johnson's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Johanson Financial Advisors Inc. (0.09%), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST (0.08%), Manning & Napier Group LLC (0.07%), PGGM Investments (0.05%), DNB Asset Management AS (0.05%) and Calamos Advisors LLC (0.05%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Hubert Joly, Joaquin Duato, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

JNJ stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., PGGM Investments, DNB Asset Management AS, Hexavest Inc., United Services Automobile Association, Commerzbank Aktiengesellschaft FI, Meag Munich Ergo Kapitalanlagegesellschaft MBH and Tocqueville Asset Management L.P.. View Insider Buying and Selling for Johnson & Johnson.

JNJ stock was purchased by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Artemis Investment Management LLP, WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST, Hamlin Capital Management LLC, Tandem Investment Advisors Inc., Advisors Capital Management LLC, Calamos Advisors LLC and Rockland Trust Co.. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince, Hubert Joly and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of JNJ stock can currently be purchased for approximately $149.17.

Johnson & Johnson has a market capitalization of $392.60 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

The official website for Johnson & Johnson is http://www.jnj.com/.

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.